Ibritumomab Intravenous and Sandostatin
Determining the interaction of Ibritumomab Intravenous and Sandostatin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Sandostatin LAR
- Ibritumomab Intravenous-Sandostatin LAR Depot
- Ibritumomab Intravenous-Sandostatin LAR Depot injection
- Ibritumomab Intravenous-Sani-Supp
- Ibritumomab Intravenous-Sani-Supp rectal
- Ibritumomab Intravenous-Sansert
- Sandostatin-Ibritumomab Tiuxetan
- Sandostatin-Ibrutinib
- Sandostatin-Ibrutinib Capsules
- Sandostatin-Ibrutinib Tablets
- Sandostatin-Ibu
- Sandostatin-IBU Tablets